HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Oberlin Selected Research

Flavin Mononucleotide (FMN)

11/2003Radiation dose as a risk factor for malignant melanoma following childhood cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Oberlin Research Topics

Disease

9Neoplasms (Cancer)
01/2017 - 08/2000
6Sarcoma (Soft Tissue Sarcoma)
08/2015 - 01/2001
5Rhabdomyosarcoma
01/2014 - 11/2000
4Hodgkin Disease (Hodgkin's Disease)
10/2016 - 04/2000
4Ewing Sarcoma (Sarcoma, Ewing)
08/2015 - 07/2001
2Primitive Neuroectodermal Tumors (PNET)
09/2002 - 11/2001
1Medulloblastoma
09/2019
1Hemangiosarcoma (Angiosarcoma)
05/2010
1Synovial Sarcoma (Synovioma)
05/2010
1Lymphoma (Lymphomas)
02/2006
1Brain Diseases (Brain Disorder)
02/2006
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
02/2006
1Renal Insufficiency (Renal Failure)
02/2006
1Malignant mesenchymal tumor
07/2005
1Pathologic Complete Response
12/2004
1Melanoma (Melanoma, Malignant)
11/2003
1Peripheral Primitive Neuroectodermal Tumors (Peripheral Neuroectodermal Tumor)
09/2002
1Residual Neoplasm
09/2002
1Pleural Effusion (Pleural Effusions)
03/2002
1Edema (Dropsy)
04/2001
1Pain (Aches)
04/2001
1Capillary Leak Syndrome
04/2001
1Hypoalbuminemia
04/2001
1Myalgia
04/2001
1Brain Neoplasms (Brain Tumor)
08/2000
1Burkitt Lymphoma (Burkitt's Lymphoma)
08/2000
1Sclerosis
04/2000

Drug/Important Bio-Agent (IBA)

3IfosfamideFDA LinkGeneric
03/2015 - 04/2001
2Alkylating AgentsIBA
08/2015 - 02/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2015 - 04/2000
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
07/2005 - 09/2000
2Pharmaceutical PreparationsIBA
04/2001 - 09/2000
2Etoposide (VP 16)FDA LinkGeneric
04/2001 - 04/2000
1Biomarkers (Surrogate Marker)IBA
05/2015
1Methylene Blue (Methylthioninium Chloride)FDA Link
02/2006
1Flavin Mononucleotide (FMN)IBA
11/2003
1Melphalan (Alkeran)FDA LinkGeneric
09/2002
1DNA (Deoxyribonucleic Acid)IBA
10/2001
1RNA (Ribonucleic Acid)IBA
10/2001
1Creatine Kinase (Creatine Phosphokinase)IBA
04/2001
1Mitoguazone (MGBG)IBA
04/2001
1Morphine (MS Contin)FDA LinkGeneric
04/2001
1Vinorelbine (Navelbine)FDA LinkGeneric
04/2001
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
09/2000
1OF 900IBA
09/2000
1Mechlorethamine (Nitrogen Mustard)FDA Link
04/2000
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2000
1Hemoglobins (Hemoglobin)IBA
04/2000
1Dacarbazine (DIC)FDA LinkGeneric
04/2000
1Vinblastine (Vinblastine Sulfate)FDA Link
04/2000
1Vincristine (Oncovin)FDA LinkGeneric
04/2000
1Prednisone (Sone)FDA LinkGeneric
04/2000
1Procarbazine (Matulane)FDA Link
04/2000
1Biological ProductsIBA
04/2000

Therapy/Procedure

10Drug Therapy (Chemotherapy)
08/2015 - 04/2000
7Radiotherapy
01/2017 - 04/2000
7Therapeutics
10/2016 - 01/2001
2Brachytherapy
04/2013 - 11/2000
1Craniospinal Irradiation
09/2019
1Time-to-Treatment
05/2015
1Neoadjuvant Therapy
03/2015
1Adjuvant Chemotherapy
09/2002
1MINE regimen
04/2001
1Hematopoietic Stem Cell Transplantation
09/2000